REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$63,42
0,00%
(0,00) 1D
13 ຕ.ລ., 16 ໂມງ 56 ນາທີ 00 ວິນາທີ GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$62,76
High
R$63,64
Low
R$62,76
Mkt. cap
77,54 ຕື້
Avg. vol.
910,00
Volume
265,00
52-wk high
R$73,13
52-wk low
R$49,91
Shares outstanding
101,14 ລ້ານ
No. of employees
15 ພັນ
Open
R$62,76
High
R$63,64
Low
R$62,76
Mkt. cap
77,54 ຕື້
Avg. vol.
910,00
Volume
265,00
52-wk high
R$73,13
52-wk low
R$49,91
Shares outstanding
101,14 ລ້ານ
No. of employees
15 ພັນ
News stories
From web sources and news partners
ad-hoc-news.de
·
5 ຊົ່ວໂມງກ່ອນ
Regeneron reports 84-week Pasatru data: stock pre-market at EUR 673.30
ad-hoc-news.de
·
21 ຊົ່ວໂມງກ່ອນ
RBC raises target for Regeneron stock to USD 810.00
The Globe and Mail
·
1 ມື້ກ່ອນ
Citi Keeps Their Hold Rating on Regeneron (REGN)
ad-hoc-news.de
·
1 ມື້ກ່ອນ
Regeneron reports Pasatru data and Citi holds Regeneron stock
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15,3 ພັນ
Founded1988
HeadquartersTarrytown, ລັດນີວຢອກ, ສະຫະລັດ
SectorBiotechnology
Websiteregeneron.com